Stocks To Buy or Sell Today, August 4: Paytm, DLF and GSK Pharma Among Shares That May Remain in Spotlight on Tuesday

Indian equity markets continue to focus on the first-quarter corporate earnings season alongside major corporate announcements, with several key stocks expected to see action in trading. Shares of Paytm, DLF, Torrent Power, and GlaxoSmithKline Pharmaceuticals (GSK Pharma) are among those in the spotlight due to quarterly financial results, strategic expansions, and business updates.

Here is a detailed breakdown of the key news triggers for these active counters.

Paytm (One97 Communications) (NSE: PAYTM)

Paytm remains in focus following key operational updates and recent trading momentum. The fintech major reported steady growth in user engagement and merchant subscription numbers, driven by expansion in its payment device footprint. Investors are closely monitoring the company's financial trajectory as it continues its push toward sustained operational profitability amid shifting regulatory and competitive dynamics in the Indian digital payments landscape. Stock Market Today: Sensex, Nifty Surge up to 1% in Early Trade As Lower Crude, FII Buying Boost Sentiment.

DLF (NSE: DLF)

Real estate leader DLF is under the spotlight as it reports its Q1 financial performance. Analysts are watching the company's pre-sales figures, project launch pipeline, and cash flow generation. Strong demand in the luxury and premium residential segments across key urban hubs like the National Capital Region (NCR) continues to serve as a primary growth driver for the developer.

Torrent Power (NSE: TORNTPOWER)

Torrent Power is in focus on account of its recent expansion into renewable energy and power distribution infrastructure, alongside its quarterly financial disclosures. The company recently announced significant solar power supply agreements and new ventures into electric mobility infrastructure, including green EV charging hubs. Market participants are tracking the impact of higher energy demand and capacity additions on the company's margin profile. When Will Stock Market Close? New Timings for F&O Traders Effective From Today.

GlaxoSmithKline Pharmaceuticals (GSK Pharma) (NSE: GSKPHARMA)

GSK Pharma is drawing investor attention as part of the ongoing healthcare sector earnings lineup. Market focus centers on the company's core prescription medicine portfolio, key vaccine segment growth, and operational efficiencies. Investors are looking for commentary on pricing pressures, raw material costs, and volume trends across key therapeutic areas.

Conclusion

With the Q1 earnings season progressing and domestic institutional inflows remaining steady, stock-specific action across counters like Paytm, DLF, Torrent Power and GSK Pharma is expected to drive near-term market momentum, even as broader domestic equity benchmark indices continue to track a mix of global macroeconomic cues and company-level earnings performance. Investors are advised to track individual company results closely rather than relying solely on index-level movement, given the earnings-driven volatility currently at play.

(Disclaimer: The information provided in this article is based on news reports and is not intended as investment advice. Investing in stocks involves risk. LatestLY advises its readers to consult with a financial advisor before making any investment decisions.)

(The above story first appeared on LatestLY on Aug 04, 2026 07:50 AM IST. For more news and updates on politics, world, sports, entertainment and lifestyle, log on to our website latestly.com).